ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 97 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $46,513,000 | +9.7% | 896,724 | 0.0% | 0.99% | -12.2% |
Q2 2022 | $42,389,000 | -38.2% | 896,724 | -7.0% | 1.13% | -24.6% |
Q1 2022 | $68,633,000 | +593.8% | 964,212 | +285.7% | 1.50% | +28.1% |
Q3 2014 | $9,893,000 | -85.1% | 250,000 | -83.8% | 1.17% | -82.6% |
Q2 2014 | $66,310,000 | +7.6% | 1,539,586 | -0.1% | 6.70% | +51.7% |
Q1 2014 | $61,628,000 | +697.9% | 1,541,078 | +253.3% | 4.42% | +331.6% |
Q2 2013 | $7,724,000 | – | 436,145 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |